Open AccessCharacterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of Asthma
Author(s) -
Magnus Nilsson,
Magdalena Rhedin,
Ramon Hendrickx,
Susanne Berglund,
Antonio Piras,
Parmis Blomgran,
Anders Cavallin,
Mia Collins,
Göran Dahl,
Bilel Dekkak,
Therese Ericsson,
Niklas Hagberg,
Ann Aurell Holmberg,
Agnes Leffler,
Anders Lundqvist,
Thomais Markou,
James Pinkerton,
Lars Rönnblom,
Stacey Siu,
Vanessa Taylor,
Tiiu Wennberg,
Dimitrios Zervas,
Arian Laurence,
Suman Mitra,
Maria G. Belvisi,
Mark A. Birrell,
Annika Borde
Publication year - 2022
Publication title -
drug design, development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s354291
Subject(s) - stat protein , janus kinase , cytokine , stat6 , pharmacology , medicine , stat3 , stat5 , immunology , signal transduction , janus kinase 1 , ovalbumin , chemokine , lung , inflammation , immune system , chemistry , interleukin 4 , receptor , biochemistry